Bin Sabbar, N. S., F. S. Alowirdi, F. A. Basakran, L. A. Al-Badr, R. A. Assiri, W. A. Alshahrani, A. Althubaiti, and M. Damlaj. “Addition of Rituximab to Hyper-CVAD Improves Overall Survival in Newly Diagnosed Burkitt leukemia/Lymphoma from the Middle East and North Africa Region”. International Journal Of Community Medicine And Public Health, vol. 6, no. 10, Sept. 2019, pp. 4199-03, doi:10.18203/2394-6040.ijcmph20194475.